Johnson & Johnson (JNJ) Short term Debt (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Short term Debt came in at $17.5 billion in Q1 2026, up 25.64% year-on-year from $13.9 billion in Q1 2025, and up 105.53% quarter-over-quarter from $8.5 billion in Q4 2025.

Johnson & Johnson (JNJ) Short term Debt (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Short term Debt across 18 years of filings, most recently posting $17.5 billion for Q1 2026.

  • Short term Debt for Q1 2026 came in at $17.5 billion, up 25.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.5 billion (up 25.64% YoY), and the FY2025 annual result was $8.5 billion, up 41.99% from the prior year.
  • Short term Debt came in at $17.5 billion for Q1 2026 at Johnson & Johnson, up from $8.5 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $18.0 billion in Q2 2023 to a low of $3.5 billion in Q4 2023.
  • The 5-year median for Short term Debt is $7.4 billion (2025), against an average of $8.5 billion.
  • Peak annual rise in Short term Debt reached 318.41% in 2023, while the deepest fall reached 72.95% in 2023.
  • Johnson & Johnson's Short term Debt stood at $4.4 billion in 2022, then retreated by 21.99% to $3.5 billion in 2023, then surged by 73.37% to $6.0 billion in 2024, then jumped by 41.99% to $8.5 billion in 2025, then jumped by 105.53% to $17.5 billion in 2026.
  • The last three Short term Debt figures came in at $17.5 billion (Q1 2026), $8.5 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 17.46 Bn
Dec 28, 2025 8.50 Bn
Sep 28, 2025 6.39 Bn
Jun 29, 2025 11.53 Bn
Mar 30, 2025 13.90 Bn
Dec 29, 2024 5.98 Bn
Sep 29, 2024 4.46 Bn
Jun 30, 2024 9.86 Bn
Mar 31, 2024 8.55 Bn
Dec 31, 2023 3.45 Bn
Oct 1, 2023 3.87 Bn
Jul 2, 2023 11.70 Bn
Apr 2, 2023 17.98 Bn
Jan 1, 2023 12.76 Bn
Oct 2, 2022 4.42 Bn
Jul 3, 2022 4.31 Bn
Apr 3, 2022 4.30 Bn
Jan 2, 2022 3.77 Bn
Oct 3, 2021 3.80 Bn
Jul 4, 2021 3.17 Bn